-
Report: 650% Spike In Cannabis Medicine Trials Prioritizing Chronic And Neuropathic Pain
Wednesday, September 6, 2023 - 5:52pm | 547Read More...Could the future of healthcare be intertwined with cannabis-based medicines? A recent report by Prohibition Partners, a data, media and tech company operating in the cannabis industry, reveals a remarkable 650% surge in clinical trials using cannabis-based medicines to alleviate symptoms...
-
DEA's Rescheduling Of Cannabis Will Have Limited Impact On Criminal Justice Reform, Says Advocate
Monday, September 4, 2023 - 1:58pm | 531Read More...Following last week’s huge news that the Health and Human Services (HHS) is seeking to reschedule cannabis to a lower federal level, the Drug Enforcement Administration (DEA) has a decision to make. "It's certainly a big deal that a federal agency is finally admitting that...
-
Weed Stocks Skyrocket, Could There Be More Upside? Analyst Draws Scenarios
Friday, September 1, 2023 - 3:49pm | 961Read More...The Department of Health and Human Services (HHS) suggested the DEA reclassify cannabis as a Schedule III controlled substance under federal law. Assistant Secretary for Health Rachel Levine's letter triggered a much-needed rally in cannabis stocks. In a recent analyst note, a...
-
Department Of Health And Human Services Rescheduling Recommendation And What It Means For U.S. Cannabis
Friday, September 1, 2023 - 1:39pm | 427Read More...It’s been a while since we’ve heard about cannabis from Washington D.C. Today, however, there’s been a significant development. A top official at the Department of Health and Human Services (HHS) has announced a recommendation to the Drug Enforcement Administration (DEA) for the...
-
Cannabis Tax Changes Could Trigger 504% Cash Flow Leap, Which Industry Players Will Benefit?
Thursday, August 31, 2023 - 4:34pm | 629Read More...The Department of Health and Human Services' recommendation to reclassify marijuana as a Schedule III drug under the Controlled Substances Act set off ripples across the cannabis market. One day following Wednesday's news, MSOS ETF (ARCA: MSOS) surged by 21%. Notable companies also...
-
Health Dept Decision To Move Cannabis To Lower-Risk Category: Bull Case Narrative For The Industry
Thursday, August 31, 2023 - 1:45pm | 758Read More...Recent news that the Department of Health and Human Services (HHS) is recommending the reclassification of marijuana as a Schedule III drug under the Controlled Substances Act has ignited significant market reactions. On the day following the report, MSOS ETF (ARCA: MSOS) surged...
-
Chuck Schumer Responds To Cannabis Rescheduling, Sen. Ron Wyden Calls It 'Historic Leap'
Wednesday, August 30, 2023 - 7:14pm | 570Read More...New York Senator Chuck Schumer (D) responded to Wednesday's news that the Dept. of Health and Human Services wrote to DEA administrator Anne Milgram calling for marijuana to be reclassified as a Schedule III drug under the Controlled Substances Act. Cannabis'...
-
HHS Secretary Confirms It Is Recommending Cannabis Be Rescheduled, Per Biden's Directive
Wednesday, August 30, 2023 - 5:47pm | 606Read More...Health and Human Services (HHS) Secretary Xavier Becerra confirmed his agency has responded to President Biden's directive to provide scheduling recommendations for cannabis to the Drug Enforcement Agency. What Happened A top official at the HHS wrote to DEA ...
-
Cannabis Stocks Soar As Gov Health Officials Call On DEA To Reschedule Marijuana: Is Legalization In Sight?
Wednesday, August 30, 2023 - 3:00pm | 452Read More...The Department of Health and Human Services is recommending to the Drug Enforcement Administration that cannabis should be reclassified as a Schedule III controlled substance under federal law, according to a report by Bloomberg on Wednesday. Currently, cannabis is a Schedule I drug,...
-
Health Officials To DEA: Ease Federal Restrictions On Cannabis - Will This Set Stage For Legalization?
Wednesday, August 30, 2023 - 12:55pm | 389Read More...A top official at the Department of Health and Human Services wrote to Drug Enforcement Agency administrator Anne Milgram calling for marijuana to be reclassified as a Schedule III drug under the Controlled Substances Act, according to a letter dated Aug. 29 seen by Bloomberg...
-
Matt Gaetz Pushes DEA Chief Milgram To Commit To Request Marijuana Review Timeline From HHS
Thursday, July 27, 2023 - 7:30pm | 449Read More...Rep. Matt Gaetz (R-Fla.) and Rep. Steve Cohen (D-Tenn.) pushed the DEA chief on the agency's plans to remove marijuana from its status as a Schedule I drug on Thursday in a House Judiciary hearing on Thursday. DEA Administrator Anne Milgram told the Subcommittee on Crime and...
-
DEA's 7 'Creative' Activities To Keep Teens Off Drugs, Hang Ten!
Wednesday, July 12, 2023 - 2:28pm | 546Read More...Yay! The DEA came up with seven activities to get a natural high that doesn't involve drugs. Snorkel, jet ski, get sunburnt. Can’t wait! “From creative expression to outdoor adventures, these activities can give you a natural high that lasts,” says the fun-loving...
-
$1 Trillion And 50 Years Later, Is The DEA's War On Drugs A Failure?
Saturday, July 8, 2023 - 5:44pm | 699Read More...The Drug Enforcement Administration (DEA) turned 50 this week, marking five decades and over $1 trillion in its unsuccessful attempt to enforce the Controlled Substances Act (CSA) by means of what is widely viewed as a failed War on Drugs. Why Unsuccessful? The CSA, created...
-
Congressional Bill Would Authorize $150M To Universities For Cannabis Research
Tuesday, June 6, 2023 - 2:31pm | 359Read More...A new House bill, Higher Education Marijuana Research Act, will provide $150 million for cannabis research funding to be earmarked for universities over five years, allowing them to utilize cannabis via partnerships with state regulatory agencies and law enforcement, reported ...
-
DEA Waited 4 Years To Penalize Opioid Distributor After Judge's Recommendation: Why? Answer Might Make You Angry
Friday, May 26, 2023 - 5:51pm | 484Read More...It appears that the DEA looked the other way as one of the nation's largest wholesale drug distributors continued to ship highly addictive painkillers for nearly four years after a judge recommended it be stripped of its license for its "cavalier disregard" of...
















